Torsten Schwede, a current member of the President’s Board of the University, is set to lead one of Switzerland's most important academic bodies. The chemist heads a research group for structural bioinformatics at the…

Prof. Torsten Schwede The ICSB honors Torsten Schwede, Professor of Structural Bioinformatics at the Biozentrum and Vice President for Research of the University of Basel, for his substantial contributions to computational…

In the past years, AlphaFold has revolutionised protein science. This Artificial Intelligence (AI) tool was trained on protein data collected by life scientists for over 50 years, and is able to predict the 3D shape of…

2023 was a year of significant scientific discoveries and exciting community activities. A major highlight was our first World Alumni Day, celebrating our global community and renewing as well as fostering connections. More…

T3 Pharmaceuticals (“T3 Pharma”) was founded in 2015 as a spin-off of the Biozentrum of the University of Basel. The company focuses on bacterial therapies for the treatment of solid tumors. The Basel-based biotech company’s…

The Ambizione fellow Dr. Janani Durairaj , project leader in the research group of Prof. Torsten Schwede, will study the protein universe of viruses in more detail. Viruses have evolved diverse pathogenic mechanisms and…

Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis. Antibodies recognize and bind to very specific structures. This allows them to direct active substances…

The objectives of the National Center of Competence in Research (NCCR) "AntiResist" are to search for new antibiotics and to develop alternative strategies to combat antibiotic-resistant pathogens. "AntiResist" is one of a…

Did the development of an artificial intelligence (AI) tool like ChatGPT surprise you personally? I think we were all surprised by the rapid pace of this development and above all by the quality and versatility of this chat…